| Business Name: |
Center For Rheumatic Diseses |
| Contact Person: |
Deanna Davenport, Manager |
| Address: |
1000 West Nifong Boulevard, Columbia, Missouri 65203 |
| Phone Number: |
(573) 882-8095 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Clinics |
| SIC Code: |
8011 |
| NAICS Code: |
6214930 |
| Share This Business: |
|
| Related Businesses: |
Mid MO Reproductive Medicine - Columbia, MO 65203
University Physicians-Fairview - Columbia, MO 65203
Crowder Sara E Md Clinic Office-Gynecologic On - Columbia, MO 65203
Physical Medicine & Rehab Clinic - Columbia, MO 65203
Missouri Digestive Health Center - Columbia, MO 65203
University Physicians - Columbia, MO 65203
University of Columbia Hosp - Columbia, MO 65203
Cancer Screening Service Inc - Columbia, MO 65203
University Family Health Center - Columbia, MO 65203
Family Health Center - Columbia, MO 65203
Solomon Family Medical Clinic - Columbia, MO 65203
Rusk Rehabilitation Center - Columbia, MO 65203
Hematology Oncolgy Intrnl Med - Columbia, MO 65203
Center-Reproductive Science - Columbia, MO 65203
Green Meadows Clinic-Pediatric - Columbia, MO 65203
|
The company Center For Rheumatic Diseses provides B2C services in the form of Clinics from its single location in Missouri.
1 to 4 employees work for Center For Rheumatic Diseses, and the business now earns $500.000 to $999.999 per annum.
Center For Rheumatic Diseses was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6214930 .
To contact Center For Rheumatic Diseses, please call Deanna Davenport, Manager with the phone number (573) 882-8095 or visit its single location at 1000 West Nifong Boulevard in Columbia, Missouri 65203.
The location of the single location can also be found using the coordinates 38.908546,-92.353414.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.